Pulmatrix, Inc. (PULM)

Pulmatrix Statistics

Total Valuation

Pulmatrix has a market cap or net worth of $17.59 million. The enterprise value is $12.99 million.

Market Cap	17.59M
Enterprise Value	12.99M

Important Dates

The last earnings date was Thursday, October 16, 2025, before market open.

Earnings Date	Oct 16, 2025
Ex-Dividend Date	n/a

Share Statistics

Pulmatrix has 3.65 million shares outstanding.

Current Share Class	3.65M
Shares Outstanding	3.65M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	9.17%
Float	3.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5,928.88
Forward PS	n/a
PB Ratio	3.76
P/TBV Ratio	3.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4,330.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.97

Current Ratio	19.97
Quick Ratio	19.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.47% and return on invested capital (ROIC) is -49.62%.

Return on Equity (ROE)	-79.47%
Return on Assets (ROA)	-47.09%
Return on Invested Capital (ROIC)	-49.62%
Return on Capital Employed (ROCE)	-131.27%
Revenue Per Employee	$1,500
Profits Per Employee	-$3.11M
Employee Count	2
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +141.09% in the last 52 weeks. The beta is 1.64, so Pulmatrix's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	+141.09%
50-Day Moving Average	4.82
200-Day Moving Average	6.33
Relative Strength Index (RSI)	50.35
Average Volume (20 Days)	17,657

Short Selling Information

The latest short interest is 5,917, so 0.16% of the outstanding shares have been sold short.

Short Interest	5,917
Short Previous Month	12,682
Short % of Shares Out	0.16%
Short % of Float	0.16%
Short Ratio (days to cover)	0.33

Income Statement

In the last 12 months, Pulmatrix had revenue of $3,000 and -$6.22 million in losses. Loss per share was -$1.70.

Revenue	3,000
Gross Profit	-7.16M
Operating Income	-6.21M
Pretax Income	-6.22M
Net Income	-6.22M
EBITDA	-6.13M
EBIT	-6.21M
Loss Per Share	-$1.70

Balance Sheet

The company has $4.79 million in cash and n/a in debt, giving a net cash position of $4.79 million or $1.31 per share.

Cash & Cash Equivalents	4.79M
Total Debt	n/a
Net Cash	4.79M
Net Cash Per Share	$1.31
Equity (Book Value)	4.73M
Book Value Per Share	1.30
Working Capital	4.72M

Cash Flow

Operating Cash Flow	-5.99M
Capital Expenditures	n/a
Free Cash Flow	-5.99M
FCF Per Share	-$1.64

Margins

Gross Margin	n/a
Operating Margin	-207,100.00%
Pretax Margin	-207,333.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pulmatrix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-34.97%
FCF Yield	-33.67%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Pulmatrix has an Altman Z-Score of -35.86 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-35.86
Piotroski F-Score	2